(Q41748125)

8 October 2017

1 reference

title

Some remarks on biological markers of Alzheimer's disease (English)

1 reference

8 October 2017

0 references

Robles A

1

1 reference

8 October 2017

1 March 1998

1 reference

8 October 2017

Neurobiology of Aging

1 reference

8 October 2017

19

1 reference

8 October 2017

2

1 reference

8 October 2017

153-157

1 reference

Apolipoprotein E gene in diffuse Lewy body disease with or without co-existing Alzheimer's disease

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Electroencephalographic Sleep in Depressive Pseudodementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Marked changes in mitochondrial DNA deletion levels in Alzheimer brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Toward a definite diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Association of apolipoprotein E E4 with vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Clinical rationale of genetic testing in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Increased insulin levels after OGTT load in peripheral blood and cerebrospinal fluid of patients with dementia of Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

[Neuroimaging in the diagnosis of Alzheimer's disease].

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Neurodegeneration, Alzheimer's disease, and beta-amyloid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

A mitochondrial DNA clone is associated with increased risk for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Blood markers in Alzheimer disease: subnormal acetylcholinesterase and butyrylcholinesterase in lymphocytes and erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

A verbal memory test with high predictive accuracy for dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

The development of mitochondrial medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Alterations in glucose metabolism in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Cytochrome oxidase deficiency in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Increased cerebrospinal fluid pyruvate levels in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Memory function in very early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Apolipoprotein E4 and Alzheimer's disease pathology in Lewy body disease and in other beta-amyloid-forming diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Reliable discrimination of elderly depressed and demented patients by electroencephalographic sleep data

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Elevated levels of the endosomal-lysosomal proteinase cathepsin D in cerebrospinal fluid in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

The assessment of diagnostic tests. A survey of current medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

The gene defects responsible for familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Detecting Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Mitochondrial DNA sequence variation in human evolution and disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2898%2900011-6

7 January 2021

10.1016/S0197-4580(98)00011-6

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9558153